Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
"Even with 35% pop...still a discount.."
https://grizzle.com/aphria-q4-2019-earnings-review-back-on-top/
Upgrades and new price targets from analysts soon to follow
Positive street sentiment with the success of the 90 day plan will drive this stock even higher.
"In the conference call, executives said they expected revenue net of excise taxes in the range of C$650 million to C$700 million. Simon said the company aims to hit a C$1 billion run rate by the end of the fiscal year"
https://www.marketwatch.com/story/aphria-shares-surge-nearly-20-after-surprise-profit-2019-08-01
WOW!!! UP ALMOST 32% AFTER HOURS. CONGRATS LONGS!!!
Apha has set a high bar (128 million in revs) for ACB to match and is profitable.
APHRIA has set a HIGH revenue bar for ACB and CGC to match. It will be interesting to see if they even break the $100 million mark- I doubt it, let alone be profitable like APHA
Congrats LONGS!!!!
Good post Rowdy. I too believe REVs will be up from last quarter. I think the ER will pleasnatly surprise a few. Consensus analysts are predicting -0.05 but I expect only 0.01 or 0.02. No writeoffs expected as told expected by Irwin in his last ER speech.
Terry Booth sold ACB on July 19th, he sold 95600 shares
https://www.canadianinsider.com/node/7?menu_tickersearch=ACB+%7C+Aurora+Cannabis
Why Aphria Stock Will Be the Next Billion-Dollar Pot Behemoth
https://investorplace.com/2019/07/why-aphria-stock-will-be-the-next-billion-dollar-pot-behemoth/
Wow. 9 MILLION SHARES!!!
https://m.nasdaq.com/symbol/apha/after-hours
That is debatable for some companies in the sector as market price is generally a function of demand. Demand for APHA will increase as the market sentiment for it becomes more positive.
In short, I do believe in a high potential for a Buyout. The price is relatively attractive in comparison to other MJ companies that have higher multiples. The potential sales revenue moving forward are very enticing as well. Having said that, the sentiment has to change foremost before this happens. In addition, a few things have to happen before a large Pharma or beverage company steps in:
• Leadership confirmation (not just interim) so investors are reassured of the company’s direction (the uncertainty is holding the SP back) this also means expanding at a reasonable pace to avoid costly acquisitions (no more farms and focus on supply agreements to sell what you are producing now);
• DD facility approval by Health Canada (capacity for edibles);
• Extraction tech must be operational; and
• More company emphasis on Global reach and markets (the company can sell their products for higher prices in the UK as opposed to North America).
Just my immediate thoughts at this time.
"It's just the normal summer blahs. The downtrend will continue for about another month before traders and liquidity return"
APHRIA grew its sales by a blistering 617% year over year in its most recent quarter, and its acquisitions are starting to pay off.
The name of the company? Aphria Inc (TSX:APHA)(NYSE:APHA).
About Aphria
Aphria is a marijuana producer with a strong focus on the medical side of the cannabis industry. Unlike Canopy and Aurora, however, it hasn’t fared overly well with recreational cannabis, with a 35% decline in recreational sales in its most recent quarter. But what the company missed on recreational, it more than made up for in medical: the company saw a 64% increase in medical cannabis produced in the nine months ended February 28th.
Additionally, the company added about $50 million in new distribution revenue from its subsidiaries CC Pharma and ABH, which serves to demonstrate that Aphria’s acquisition strategy actually is paying off, contrary to the claims of short-seller research reports stating that the company was spending exorbitant amounts of money on virtually nothing.
Buy This 1 Weed Stock Instead of Aurora Cannabis (TSX:ACB)https://ca.finance.yahoo.com/news/buy-1-weed-stock-instead-165041996.html
Health Canada License announcement later this afternoon around 4:30pm EST.
Although, Diamond is not expected until July 5 or 12th. Still, last minute price surge can be expected today.
Aphria to supply Cannabis for huge UK clinical trial Through Althea.
Aphria owns 20% of Althea, but supplies 100% of their oils (Althea’s medicinal cannabis products are currently greenhouse grown and manufactured by Aphria Inc., a licensed Canadian producer of medicinal cannabis and part owner of Althea)
https://wcsecure.weblink.com.au/pdf/AGH/02116984.pdf
Always a GOOD sign when insiders buy shares.
Lots of buying on June 20th
https://www.canadianinsider.com/node/7?menu_tickersearch=APHA+%7C+Aphria
Have a nice weekend as well. Keep us posted if you hear anything during the weekend.
Some news on the horizon?
If that happens your Liberty Health Sciences Inc. (LHSIF) stock will drop drastically as well
Something is up? Nasdaq premarket up 25 cents
Agree 100%. Aphria upside potential is HUGE
Similar to what you did...sell at a loss solely due to greasy short report?
Thanks for sharing this detailed package.
Aphria adds to planned portfolio of vapes & concentrates with PAX Labs agreement
Solei, RIFF and Aphria medical cannabis to be available for the PAX Era device and platform
LEAMINGTON, ON, June 7, 2019 /PRNewswire/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today announced an agreement with San Francisco-based PAX Labs, Inc. ("PAX"), a leader in the design and development of premium cannabis vaporization devices, that will enable Aphria to provide premium cannabis extracts in pods designed for use with PAX's innovative Era device and platform. The Company plans to introduce PAX pods for both adult-use consumers and medical patients, pending anticipated changes to the Cannabis Act to permit the sale of cannabis extracts for vaporization.
"If APHA can restore its reputation, Aphria stock could rise tremendously. APHA trades at a steep discount to its peers, due to last year's allegations. However, it's also well-positioned to become one of the industry's top producers. Moreover, its position in Germany's market will bolster its earnings growth. If APHA's multiple expands to levels that are comparable to those of other cannabis stocks, the owners of Aphria stock will see huge gain, assuming another firm does not buy APHA first."
https://www.nasdaq.com/article/aphria-stock-could-deliver-massive-gains-cm1160327
Perhaps announcement of new CEO or President. Some large transactions after-hours
That would be a big mistake considering the UPSIDE potential.
Its all about Trumps threats and plans to impose more tariffs..
https://www.msn.com/en-ca/money/topstories/north-american-stocks-down-after-trump-plan-to-impose-tariffs-on-mexico/ar-AACcDzq?ocid=spartandhp
Yes shocking but as you can see APHA is holding up better than other MJ companies. It is more a Economy wide thing as opposed to sector/industry that is a result of "trade wars".
"APHRIA is of seven stocks primed to take off"
"If you are looking for a marijuana stock with plenty of growth potential, look no further. Low-cost Canadian cannabis producer Aphria (NYSE:APHA) has only buy ratings from the Street. Their average analyst price target of $11 USD indicates shares can spike 60% from current levels. That’s on top of the 11% growth already experienced year-to-date."
https://finance.yahoo.com/news/7-stocks-buy-monster-growth-172524794.html
Currently, 12 analysts are covering Aphria stock—one more compared to the previous month. Among the 12 analysts, three recommended a “strong buy,” while six recommended a “buy” on the stock. The consensus recommendation for Aphria is a “buy.” The consensus recommendation didn’t change from the previous month.
https://marketrealist.com/2019/05/aphria-analysts-ratings-and-target-price/
Because it is like what you said before -"Love cheaper entries". Keep dreaming though it is a reality for IAN but not APHA
ONLY WEAK HANDS SELL
Awesome up over 4.5% today in Canada
Hundreds of thousands of shares bought in the last 3 minutes including a 250k lot bought by Morgan Stanley at 4pm.
Remember CDN markets open Monday. US markets closed. This momentum will carry on Monday and definitely Tuesday.
SPIKING OVER 13%
Yup good selling opportunity for ACB shareholders to buy APHA since Jeffries gave a higher valuation for APHA